Next Article in Journal
Integrating Articular Cartilage Histopathology with CTX-II and COMP as Synovial Fluid Biomarkers for a Comprehensive Analysis in Osteoarthritis Evaluation
Previous Article in Journal
Optimizing Breast Cancer Classification: A Comparative Analysis of Supervised and Unsupervised Machine Learning Techniques
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Proceedings
Volume 103
Issue 1
10.3390/proceedings2024103041
proceedings-logo
Submit to this Journal
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Bioinformatic Analysis of the Anti-Cancer Effects of Safranal via the p53 Signaling Pathway in Cervical Cancer Cell Lines †

by
Souandaou Athoumani Ali
*,
Fatma Gül Özcan
and
Ömür Karabulut Bulan
Institute of Graduate Studies in Science, Department of Biology, Faculty of Science, Istanbul University, 34452 Istanbul, Turkey
*
Author to whom correspondence should be addressed.
†
Presented at the 3rd International Electronic Conference on Biomolecules, 23–25 April 2024; Available online: https://sciforum.net/event/IECBM2024/.
Proceedings 2024, 103(1), 41; https://doi.org/10.3390/proceedings2024103041
Published: 12 April 2024
(This article belongs to the Proceedings of The 3rd International Electronic Conference on Biomolecules)
Versions Notes

Cervical cancer is a widespread type of cancer among women worldwide, caused by an HPV virus infection. In recent years, researchers have focused on developing new targeted treatment approaches to reduce or eliminate side effects caused by standard treatment methods used in clinics. Our research aimed to investigate the p53 signaling pathways expressed in the genomic profile of HeLa and C-4 I using RNA sequencing after applying safranal. The goal is to explore the biological processes, molecular functions, and genes involved in that pathway.
To analyze the genome profile, we applied Safranal to the cervical cancer cell lines HeLa and C-4 I for 24 h. A sequencing library was created using the RNAs isolated at the end of the incubation period. After sequencing with the DNBEQ library, we analyzed p53 signaling pathways, KEGG pathways, Gene Ontology projects, cluster heat maps, and protein-protein interactions.
Based on KEGG and GO ontology, we found that safranal down-regulated p53 signaling pathway in Hela and C-4 I cells. In total, 11 and 9 genes of HeLa and C-4 I respectively are involved in this pathway. We also observed that cyclin D and cyclin E expressions were up-regulated in HeLa and C-4 I cells, which conducted cell cycle arrest in the G1 phase. We also identified the expression of CASP-8 and FAS in HeLa cells while PIG was expressed in C-4I cells, which reflected the induction of apoptosis through extrinsic and mitochondrial pathways. Furthermore, we found that safranal inhibits angiogenesis and metastasis mechanism processes based on the expressions of CD82, and PAI in HeLa cells, and BAI-1 in C-4 I cells. Additionally, the effect of safranal on DNA has been discovered through the activation of DNA damage repair mechanism. Finally, we used heat map cluster analysis to demonstrate the differential expression of genes in control and safranal-treated cells, and their functions were determined using the KEGG map.
In conclusion, these data showed that the application of safranal leads to the downregulation of p53 signaling pathway, which showed its potential anti-cancer effects on cervical cancer cell lines, HeLa and C-4 I.

Author Contributions

S.A.A.: Conceptualization, methodology, software, formal analysis, writing—original draft preparation and writing—review and editing; F.G.Ö.: validation, visualization, supervision, project administration, funding acquisition; Ö.K.B.: project administration, funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by Scientific Research Projects Coordination Unit of Istanbul University. Project number: FDK-2022-38981.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ali, S.A.; Özcan, F.G.; Bulan, Ö.K. Bioinformatic Analysis of the Anti-Cancer Effects of Safranal via the p53 Signaling Pathway in Cervical Cancer Cell Lines. Proceedings 2024, 103, 41. https://doi.org/10.3390/proceedings2024103041

AMA Style

Ali SA, Özcan FG, Bulan ÖK. Bioinformatic Analysis of the Anti-Cancer Effects of Safranal via the p53 Signaling Pathway in Cervical Cancer Cell Lines. Proceedings. 2024; 103(1):41. https://doi.org/10.3390/proceedings2024103041

Chicago/Turabian Style

Ali, Souandaou Athoumani, Fatma Gül Özcan, and Ömür Karabulut Bulan. 2024. "Bioinformatic Analysis of the Anti-Cancer Effects of Safranal via the p53 Signaling Pathway in Cervical Cancer Cell Lines" Proceedings 103, no. 1: 41. https://doi.org/10.3390/proceedings2024103041

APA Style

Ali, S. A., Özcan, F. G., & Bulan, Ö. K. (2024). Bioinformatic Analysis of the Anti-Cancer Effects of Safranal via the p53 Signaling Pathway in Cervical Cancer Cell Lines. Proceedings, 103(1), 41. https://doi.org/10.3390/proceedings2024103041

Article Metrics

Back to TopTop